Nov-Dec 2007
New One Step Synthesis of 3,5-Disubstituted 1,2,4-Oxadiazoles
1531
The general formula of the parent oxadiazoles with
corresponding numbering scheme is given below:
111.65 (C6), 160.25 (C7), 170.38 (C8), 104.06 (C9), 152.23 (C10),
109.11 (C11), 130.12 (C12), 109.11 (C13), 152.23 (C14),
substituent 55.02 and 55.73. MALDI-TOFMS: m/z 343 (M +1).
3,5-Bis(4-methylphenyl)-1,2,4-oxadiazole (2i). 1H nmr (DMSO-
d6): ꢀ (ppm) 7.21-7.30 (m, 4H); 7.76 (d, J = 7.93 Hz, 2H); 7.87 (d, J
= 7.93 Hz, 2H), 2.31 (s, 3H) CH3, 2.35 (s, 3H) CH3. 13C nmr
(DMSO-d6): ꢀ (ppm) 175.55 (C1), 127.44 (C2), 131.19 (C3), 129.17
(C4), 143.53 (C5), 129.17 (C6), 131.19 (C7), 168.78 (C8), 127.02 (C9),
129.23 (C10), 128.72 (C11), 141.17 (C12), 128.72 (C13), 129.23 (C14),
substituent 20.85 and 21.07. MALDI-TOFMS: m/z 251 (M +1).
3,5-Bis(4-chlorophenyl)-1,2,4-oxadiazole (2j). 1H nmr
(DMSO-d6): ꢀ (ppm) 7.03 (d, J = 7.03 Hz, 2H); 7.11 (d, J = 7.95
Hz, 2H); 7.49 (d, J = 7.03 Hz, 2H); 7.87 (d, J = 7.33 Hz, 2H).
13C nmr (DMSO-d6): ꢀ (ppm) 170.89 (C1), 125.18 (C2), 132.11
(C3), 128.55 (C4),139.40 (C5),128.76 (C6), 132.11 (C7), 166.32
(C8), 124.31 (C9), 129.68 (C10),127.12(C11),136.15 (C12), 127.12
(C13), 129.68 (C14). MALDI-TOFMS: m/z 292 (M +1).
11
4
3
10
12
13
5
9
N
2
8
1
R
R
6
14
7
N
O
3,5-Bis(phenyl)-1,2,4-oxadiazole (2a). 1H nmr ( DMSO-d6): ꢀ
(ppm) 7.67 (m, 6H); 8.09 (d, J = 7.63 Hz, 1H); 8.13 (d, J = 7.63
Hz, 1H); 8.17 (d, J = 6.41 Hz, 1H); 8.21(d, J = 6.41 Hz, 1H). 13C
nmr (DMSO-d6): ꢀ (ppm) 175.42 (C1), 126.12 (C2), 129.56 (C3),
129.27 (C4), 133.36 (C5), 129.27 (C6), 129.56 (C7), 168.25 (C8),
123.35 (C9), 127.90 (C10), 127.09 (C11), 131.66 (C12), 127.09
(C13), 127.90 (C14). MALDI-TOFMS: m/z 223 (M +1).
3,5-Bis(2-pyridyl)-1,2,4-oxadiazole (2b). 1H nmr (DMSO-
d6): ꢀ (ppm) 7.65 (t, J = 6.10 Hz, 1H); 7.75 (t, J = 6.71 Hz, 1H);
8.13 (m, 3H); 8.36 (d, J = 7.63 Hz, 1H); 8.84 (d, J = 6.72 Hz,
2H). 13C nmr (DMSO-d6): ꢀ (ppm) 174.89 (C1), 145.46 (C2),
124.51 (C3), 138.19 (C4), 127.58 (C5), 150.58 (C6), 168.95 (C8),
142.66 (C9), 150.35 (C11), 126.28 (C12), 137.81 (C13), 123.44
(C14). MALDI-TOFMS: m/z 225 (M +1).
3,5-Bis(4-nitrophenyl)-1,2,4-oxadiazole (2k). 1H nmr
(DMSO-d6): ꢀ (ppm) 8.08 (d, J = 8.56 Hz, 2H); 8.18-8.30 (m,
6H). 13C nmr (DMSO-d6):ꢀ (ppm) 171.37 (C1), 139.89 (C2),
130.66 (C3), 123.76 (C4),150.16 (C5), 130.66 (C6), 128.86(C7),
167.25 (C8), 135.19 (C9), 128.86 (C10),123.40(C11), 149.00 (C12),
123.40 (C13), 123.76 (C14). MALDI-TOFMS: m/z 313 (M +1).
3,5-Bis(3-pyridyl)-1,2,4-oxadiazole (2c). 1H nmr (DMSO-
d6): ꢀ (ppm) 7.70 (m, 2H); 8.45 (t, J= 3.36 Hz, 1H); 8.56 (t, J=
7.93Hz, 1H); 8.82 (d, J= 3.36 Hz, 1H); 8.90 (d, J= 3.36 Hz, 1H);
9.26 (s,1H); 9.36(s,1H). 13C nmr (DMSO-d6): ꢀ (ppm) 173.75
(C1), 121.80 (C2), 148.11 (C3), 153.38 (C5), 124.08 (C6), 135.22
(C7), 166.18 (C8), 119.42 (C9), 147.40 (C10), 152.12 (C12),
123.97 (C13), 134.34 (C14). MALDI-TOFMS: m/z 225 (M +1).
REFERENCES AND NOTES
*
Corresponding author. Tel.: +33-320-337-746; fax: +33-320-
436-814; E-mail address: michel.lagrenee@ensc-lille.fr (Michel
Lagrenée).
[1] Oussaid, B.; Moeini, L.; Garriques, B.; Villemin, D.
Phosphorus, Sulfur and Silicon 1993, 23, 85.
1
3,5-Bis(4-pyridyl)-1,2,4-oxadiazole (2d). H nmr (DMSO-d6): ꢀ
(ppm) 7.99 (d, J = 4.10 Hz, 2H); 8.07 (d, J = 4.22 Hz, 2H); 8.83 (d, J
= 4.22 Hz, 2H); 8.90 (d, J = 4.10 Hz, 2H). 13C nmr (DMSO-d6): ꢀ
(ppm) 174.55 (C1), 132.99 (C2), 121.28 (C3), 151.05 (C4), 151.05
(C6), 121.28 (C7), 167.19 (C8), 130.00 (C9), 120.97 (C10), 150.75
(C11), 150.75 (C13), 120.97 (C14). MALDI-TOFMS: m/z 225 (M +1).
3,5-Bis(3-methoxyphenyl)-1,2,4-oxadiazole (2e). 1H nmr
(DMSO-d6): ꢀ (ppm) 7.18 (d, J = 6.11 Hz, 2H); 7.29 (d, J = 8.25
Hz, 2H) 7.51-7.74 (m, 4H) 3.86 (s, 6H) OCH3. 13C nmr (DMSO-
d6): ꢀ (ppm) 175.24 (C1), 127.29 (C2), 130.84 (C3), 130.51 (C4),
117.50 (C5), 168.12 (C6), 119.39 (C7), 159.66 (C8), 124.41 (C9),
120.20 (C10), 120.20 (C11), 112.43 (C12), 159.60 (C13), 111.93 (C14),
substituent 55.31 and 55.49. MALDI-TOFMS: m/z 283 (M +1).
3,5-Bis(4-methoxyphenyl)-1,2,4-oxadiazole (2f). 1H nmr
(DMSO-d6): ꢀ (ppm) 7.10 (d, J = 8.56 Hz, 2H); 7.17 (d, J = 8.86
Hz, 2H); 8.0 (d, J = 8.86 Hz, 2H); 7.11 (d, J = 8.56 Hz, 2H) 3.83
(s, 3H) OCH3 3.86 (s,3H) OCH3. 13C nmr (DMSO-d6): ꢀ (ppm)
174.96 (C1), 118.55 (C2), 129.89 (C3), 114.98 (C4), 163.05 (C5),
114.63 (C6), 129.89 (C7), 167.79 (C8), 115.79 (C9), 128.75 (C10),
114.63 (C11), 161.71 (C12), 114.98 (C13), 128.75 (C14),
substituent 55.39 and 55.64. MALDI-TOFMS: m/z 283 (M +1).
3,5-Bis(3,4-dimethoxyphenyl)-1,2,4-oxadiazole (2g). 1H nmr
(DMSO-d6): ꢀ (ppm) 6.76 (d, J = 8.55Hz, 4H); 7.57 (s, 2H), 3.85
(s, 12H) OCH3. 13C nmr (DMSO-d6): ꢀ (ppm) 173.14 (C1),
129.94 (C2), 114.04 (C3), 157.37 (C4), 154.22 (C5), 121.02 (C6),
126.31 (C7), 166.89 (C8), 125.66 (C9), 107.72 (C10), 152.43
(C11), 153.86 (C12), 111.13 (C13), 124.28 (C14), substituent 55.46
and 56.81. MALDI-TOFMS: m/z 343 (M +1).
[2] Milcent, R.; Barbier, G.J. Heterocycl. Chem. 1983, 20, 77.
[3] Mazzone, G.; Bonina, F. Edizione Scientifica 1979, 34(5),
390.
[4] Kenneth, D. R.; John, M. N. Bioorganic & Med. Chem. Lett.
2001, 11,753.
[5] Alagawadi, K. R.; Mahajanshetti, C. S.; Jalalpure, S. S.
Indian J. Heterocycl. Chem. 2005, 14(4), 315.
[6] Tyrkov, A. G.; Sukhenko, L. T. Pharm. Chem. J. 2004,
38(7), 376.
[7] Wang, Y.; Miller, R. L.; Sauer, D. R.; Djuric, S. W. Org.
Lett. 2005, 7, 925.
[8] Kaboudin, B.; Navaee, K. Heterocycles 2003, 60, 2287.
[9] Quadrelli, P.; Invernizzi, A. G.; Falzoni, M.; Caramella, P.
Tetrahedron 1997, 53, 1787.
[10] Hebert, N.; Hannah, A. L.; Sutton, S. C. Tetrahedron Lett.
1999, 40, 8547.
[11] Lebrini, M.; Bentiss, F.; Vezin, H.; Lagrenée, M. Appl. Surf.
Sci. 2005, 252, 950.
[12] Bentiss, F.; Lebrini, M.; Vezin, H.; Lagrenée, M. Mat. Chem.
Phys. 2004, 87, 18.
[13] Donohue, J. J. Am. Chem. Soc. 1956, 78, 4172.
[14] Hamilton, W. C. Acta Crist. 1961, 14, 95.
[15] Mernari, B.; Abraham, F.; Lagrenée, M.; Drillon, M.; Legall,
P. J. Chem. Soc. Dalton Trans. 1993 1707.
[16] Molina, P.; Alajarin, M.; Ferao, A. Synthesis 1986, 10, 843.
[17] da Costa Leite, L. F. C.; Srivastava, R. M.; Cavalcanti, A. P.
Bulletin des Sociétés Chimiques Belges 1989, 98(3), 203.
[18] Nuriev, V. N.; Zyk, N. V.; Vatsadze, S. Z. Arkivoc 2005, 4,
208.
[19] Zhou, T.; Chen, Z. C. Synth. Commun. 2002, 32(6), 887.
[20] Romdhane, A.; Gharbi, R.; Mighri, Z. Heterocycl. Com.
2004, 10(2-3), 151.
[21] Vadon-Le Goff, S.; Boucher, J.-L.; Mansuy, D. Comptes
Rendus de l'Académie des Sciences, Serie IIc: Chimie 2000, 3, 785.
3,5-Bis(2,6-dimethoxyphenyl)-1,2,4-oxadiazole (2h). 1H
nmr (DMSO-d6): ꢀ (ppm) 6.75 (d, J = 8.53Hz, 4H); 7.55 (d, J =
8.55Hz, 2H), 3.85 (s, 12H) OCH3. 13C nmr (DMSO-d6): ꢀ (ppm)
177.52 (C1), 106.71 (C2), 160.25 (C3), 111.65 (C4), 133.47 (C5),